- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 18.44M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.62M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.77M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $20.79M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $21.94M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $33.67M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $34.86M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $45.42M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $50.22M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $92.85M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $97.25M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 13.68M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $244K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$4.52M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $36.24M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $39.38M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.26 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.26 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.54M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $296K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$3.56M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$4.46M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | −$620K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $14.24M |
| Revenue | Q1 2025 · Mar 31, 2024 | $13.62M |